These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27294367)

  • 1. Persistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter Imaging.
    Hong JY; Sunwoo MK; Oh JS; Kim JS; Sohn YH; Lee PH
    PLoS One; 2016; 11(6):e0157410. PubMed ID: 27294367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
    Chung SJ; Yoo HS; Moon H; Oh JS; Kim JS; Park YH; Hong JY; Ye BS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):169-174. PubMed ID: 28912301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of ¹²³I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): a 2-year follow-up study.
    Kim JS; Oh YS; Kim YI; Yang DW; Chung YA; You IeR; Lee KS
    Arch Gerontol Geriatr; 2013; 56(1):124-8. PubMed ID: 22633343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of FP-CIT PET in pure white matter hyperintensities-related vascular parkinsonism.
    Lee YH; Lee S; Chung SJ; Yoo HS; Jung JH; Baik K; Ye BS; Sohn YH; Yun M; Lee PH
    Parkinsonism Relat Disord; 2021 Jan; 82():1-6. PubMed ID: 33220520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT.
    Mäkinen E; Joutsa J; Jaakkola E; Noponen T; Johansson J; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
    J Neurol; 2019 Apr; 266(4):826-834. PubMed ID: 30687897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated Virchow-Robin Space and Dopamine Transporter Imaging in the Striatum of Patients with Parkinsonism.
    Lee D; Hong IK; Ahn TB
    Can J Neurol Sci; 2015 Jul; 42(4):248-54. PubMed ID: 26153041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [
    Jaakkola E; Joutsa J; Mäkinen E; Noponen T; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
    J Neurol Sci; 2019 Sep; 404():124-127. PubMed ID: 31374410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different loss of dopamine transporter according to subtype of multiple system atrophy.
    Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
    Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
    Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased thalamic monoamine availability in drug-induced parkinsonism.
    Oh YS; Yoo SW; Lyoo CH; Kim JS
    Sci Rep; 2022 Mar; 12(1):3749. PubMed ID: 35260679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uneven age effects of [(18)F]FP-CIT binding in the striatum of Parkinson's disease.
    Lee CS; Kim SJ; Oh SJ; Kim HO; Yun SC; Doudet D; Kim JS
    Ann Nucl Med; 2014 Nov; 28(9):874-9. PubMed ID: 25008292
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang HJ; Park SH; Seo M; Weon YC; Kim Y
    Neurotoxicology; 2018 Jan; 64():78-84. PubMed ID: 28259768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of dopamine transporter imaging in subtypes of multiple system atrophy.
    Bu LL; Liu FT; Jiang CF; Guo SS; Yu H; Zuo CT; Wu P; Wang J
    Acta Neurol Scand; 2018 Aug; 138(2):170-176. PubMed ID: 29573392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.